» Articles » PMID: 25981504

Right Intraventricular Dyssynchrony in Idiopathic, Heritable, and Anorexigen-Induced Pulmonary Arterial Hypertension: Clinical Impact and Reversibility

Abstract

Objectives: The aim of this study was to determine the prevalence of right intraventricular dyssynchrony, its determinants and prognostic impact in idiopathic, heritable, and anorexigen-induced pulmonary arterial hypertension.

Background: Right ventricular dyssynchrony has been described in pulmonary arterial hypertension, but no evidence is available on its prognostic impact and evolution after therapy.

Methods: In 83 consecutive therapy-naïve patients, right ventricular dyssynchrony was evaluated by 2-dimensional speckle-tracking echocardiography calculating the standard deviation of the times to peak-systolic strain for the 4 mid-basal right ventricular segments (RV-SD4). After baseline (World Health Organization [WHO] class, pulmonary hemodynamics, 6-min walk test [6 MWT]), a second assessment was performed after 12 months or when clinical worsening occurred.

Results: Patients with right ventricular dyssynchrony (RV-SD4 >18 ms) had advanced WHO class, worse 6 MWT, right ventricular remodeling, and hemodynamic profile compared with patients ≤ 18 ms. Determinants of dyssynchrony included pulmonary vascular resistance, QRS duration, and right ventricular end-diastolic area (r(2) = 0.38; p < 0.000001). At 12 months, 32.5% of patients presented clinical worsening (actuarial rates: 19% at 6 months, 31% at 1 year). Multivariable models for clinical worsening prediction showed that the addition of RV-SD4 to clinical and hemodynamic variables (WHO IV, 6 MWT, and cardiac index) significantly increased the prognostic power of the model (0.74 vs. 0.81; p = 0.005, 95% confidence interval [CI]: 0.02 to 0.11). Receiver operating characteristic analysis identified RV-SD4 ≥ 23 ms as the best cutoff value for clinical worsening prediction (95% negative predictive value). At 12 months, normalization of dyssynchrony was achieved in patients with a large reduction of pulmonary vascular resistance (-42 ± 4%).

Conclusions: Right ventricular dyssynchrony is frequent in pulmonary arterial hypertension, is an independent predictor of clinical worsening, and might regress during effective treatments.

Citing Articles

Echocardiography of the right heart in pulmonary arterial hypertension: insights from the ULTRA RIGHT VALUE study.

Giudice F, Escribano-Subias P, Tello K, Kopec G, Ghio S, Giannakoulas G Eur Heart J Imaging Methods Pract. 2025; 3(1):qyae121.

PMID: 39816928 PMC: 11733976. DOI: 10.1093/ehjimp/qyae121.


Pathophysiology of the right ventricle and its pulmonary vascular interaction.

Hemnes A, Celermajer D, DAlto M, Haddad F, Hassoun P, Prins K Eur Respir J. 2024; 64(4).

PMID: 39209482 PMC: 11525331. DOI: 10.1183/13993003.01321-2024.


Risk stratification and treatment goals in pulmonary arterial hypertension.

Dardi F, Boucly A, Benza R, Frantz R, Mercurio V, Olschewski H Eur Respir J. 2024; 64(4).

PMID: 39209472 PMC: 11525341. DOI: 10.1183/13993003.01323-2024.


Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes.

Abouzaid A, Ali K, Jatoi S, Ahmed M, Ahmad G, Nazim A Ann Noninvasive Electrocardiol. 2024; 29(5):e70010.

PMID: 39205610 PMC: 11358588. DOI: 10.1111/anec.70010.


Optimal combination of right ventricular functional parameters using echocardiography in pulmonary arterial hypertension.

Li Q, Zhang Y, Cui X, Lu W, Ji Q, Zhang M ESC Heart Fail. 2024; 11(5):2694-2706.

PMID: 38488337 PMC: 11424360. DOI: 10.1002/ehf2.14752.